Phase II Study of Rapamycin in Pancreatic Cancer
$0R01FY2004FDFDA
Johns Hopkins University, Baltimore MD
Investigators
Abstract
Abstract Not Provided
View original record on NIH RePORTER →Johns Hopkins University, Baltimore MD
Abstract Not Provided
View original record on NIH RePORTER →